Aurobindo Pharma arm in Puerto Rico to halt production for expansion works
Aurobindo Pharma’s wholly owned step-down subsidiary in Puerto Rico, Auro PR Inc., will halt manufacturing to facilitate a restructuring of its facility from next month.
Auro PR Inc | 06/07/2023 | By Sudeep Soparkar | 577
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy